|
1
|
Andzane D, Zodzika J, Jermakova I, Senfelde I, Utorova M, Rezeberga D. Efficacy of Topical Treatment of Low-Risk Cervical Preinvasive Lesions with Glycyrrhizinic Acid. J Clin Med 2024; 14:136. [PMID: 39797219 PMCID: PMC11721012 DOI: 10.3390/jcm14010136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2024] [Revised: 12/15/2024] [Accepted: 12/27/2024] [Indexed: 01/13/2025] Open
Abstract
Background/Objectives: The study aimed to investigate the efficacy of medication treatment with glycyrrhizinic acid for cervical intraepithelial neoplasia (CIN) 1 lesions. Methods: Women with histologically confirmed CIN 1 in cervical biopsies were included in the prospective study. Participants of the study group used glycyrrhizinic acid spray (Epigen spray) topically 10 days (Epigen 10-day subgroup) or 20 days (Epigen 20-day subgroup) per month for 6 months. Women in the control group had no treatment. There were two follow-up visits 6 months apart. All patients were screened for human papillomavirus (HPV) before enrollment and during the first follow-up visit. Results: There were 50 patients in the Epigen group and 50 patients in the control group. At the first follow-up visit, in the histological findings, progression to CIN 2+ was 6.7% in the Epigen 20-day subgroup, 31.1% in the control group, and the persistence of CIN 1 was 86.7% in the Epigen 20-day subgroup and 62.2% in the control group, p = 0.03. Large loop excision of the transformation zone (LLETZ) was statistically significantly more frequent in the control group after the first follow-up visit (10% in the Epigen 20-day subgroup vs. 30% in the control group, p = 0.032). No such relationships were found during the second follow-up visit. Conclusions: The vaginal spray of the glycyrrhizinic acid used 20 days per month appears to decrease the risk of the progression of CIN 1 lesions, with the need to perform LLETZ. However, a similar effect is not observed after stopping usage.
Collapse
Affiliation(s)
- Diana Andzane
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
- Department of Obstetrics and Gynaecology, Rīga Stradiņš University, Miera street 45, LV 1013 Riga, Latvia
- Riga Maternity Hospital, Miera Street 45, LV 1013 Riga, Latvia
- Department of Clinical Skills and Medical Technologies, Rīga Stradiņš University, Anninmuizas bulvaris 26a, LV 1067 Riga, Latvia
| | - Jana Zodzika
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
- Department of Obstetrics and Gynaecology, Rīga Stradiņš University, Miera street 45, LV 1013 Riga, Latvia
| | - Irina Jermakova
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
| | - Ilva Senfelde
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
| | - Marina Utorova
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
| | - Dace Rezeberga
- Gynaecology Clinic, Riga East Clinical University Hospital, Hipokrata Street 2, LV 1079 Riga, Latvia; (J.Z.); (I.J.); (I.S.); (M.U.); (D.R.)
- Department of Obstetrics and Gynaecology, Rīga Stradiņš University, Miera street 45, LV 1013 Riga, Latvia
- Riga Maternity Hospital, Miera Street 45, LV 1013 Riga, Latvia
| |
Collapse
|
|
2
|
Varlamova AI, Movsesyan SO, Arkhipov IA, Khalikov SS, Arisov MV, Kochetkov PP, Abramov VE, Il’in MM, Lokshin BV. Biological Activity and Pharmacokinetic Behavior of Fenbendazole Integrated into a Supramolecular Delivery System with Licorice Extract and Sodium Dioctyl Sulfosuccinate. BIOL BULL+ 2020. [DOI: 10.1134/s1062359020060138] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
|
3
|
Badria F, Ibrahim M, El-Senduny F, Youssef M, Elimam D, Abdel Bar F. Acetyl glycyrrhetinic acid methyl ester as a promising glycyrrhizin derivative against the breast cancer cells (MCF-7). JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES 2019. [DOI: 10.4103/jrptps.jrptps_60_18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
|
4
|
Sweeteners as food additives in the XXI century: A review of what is known, and what is to come. Food Chem Toxicol 2017; 107:302-317. [DOI: 10.1016/j.fct.2017.06.046] [Citation(s) in RCA: 133] [Impact Index Per Article: 16.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Revised: 06/26/2017] [Accepted: 06/28/2017] [Indexed: 01/07/2023]
|